| Year |
Citation |
Score |
| 2013 |
Manta S, El Mansari M, Debonnel G, Blier P. Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 459-70. PMID 22717062 DOI: 10.1017/S1461145712000387 |
0.474 |
|
| 2010 |
Lucas G, Du J, Romeas T, Mnie-Filali O, Haddjeri N, Piñeyro G, Debonnel G. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat. Plos One. 5: e9253. PMID 20169084 DOI: 10.1371/Journal.Pone.0009253 |
0.505 |
|
| 2009 |
Manta S, Dong J, Debonnel G, Blier P. Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation. Journal of Psychiatry & Neuroscience : Jpn. 34: 272-80. PMID 19568478 |
0.401 |
|
| 2009 |
Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 457-65. PMID 19345072 DOI: 10.1016/J.Euroneuro.2009.01.015 |
0.34 |
|
| 2009 |
Manta S, Dong J, Debonnel G, Blier P. Optimization of vagus nerve stimulation parameters using the firing activity of serotonin neurons in the rat dorsal raphe. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 250-5. PMID 19150228 DOI: 10.1016/J.Euroneuro.2008.12.001 |
0.476 |
|
| 2008 |
Lucas G, Rymar VV, Sadikot AF, Debonnel G. Further evidence for an antidepressant potential of the selective sigma1 agonist SA 4503: electrophysiological, morphological and behavioural studies. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 11: 485-95. PMID 18364064 DOI: 10.1017/S1461145708008547 |
0.482 |
|
| 2008 |
Sato H, Skelin I, Debonnel G, Diksic M. Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites. Brain Research Bulletin. 75: 545-55. PMID 18355630 DOI: 10.1016/J.Brainresbull.2007.09.005 |
0.471 |
|
| 2008 |
Berney A, Nishikawa M, Benkelfat C, Debonnel G, Gobbi G, Diksic M. An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study. Neurochemistry International. 52: 701-8. PMID 17928105 DOI: 10.1016/J.Neuint.2007.08.021 |
0.454 |
|
| 2007 |
Bambico FR, Katz N, Debonnel G, Gobbi G. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 11700-11. PMID 17959812 DOI: 10.1523/Jneurosci.1636-07.2007 |
0.523 |
|
| 2007 |
Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S, Lambas-Senas L, Wiborg O, Haddjeri N, Piñeyro G, Sadikot AF, Debonnel G. Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron. 55: 712-25. PMID 17785179 DOI: 10.1016/J.Neuron.2007.07.041 |
0.5 |
|
| 2007 |
Debonnel G, Saint-André E, Hébert C, De Montigny C, Lavoie N, Blier P. Differential physiological effects of a low dose and high doses of venlafaxine in major depression International Journal of Neuropsychopharmacology. 10: 51-61. PMID 16690006 DOI: 10.1017/S1461145705006413 |
0.461 |
|
| 2007 |
Blier P, Saint-André E, Hébert C, De Montigny C, Lavoie N, Debonnel G. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers International Journal of Neuropsychopharmacology. 10: 41-50. PMID 16690005 DOI: 10.1017/S1461145705006395 |
0.445 |
|
| 2007 |
Bermack JE, Debonnel G. Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors. Journal of Psychopharmacology (Oxford, England). 21: 85-92. PMID 16533864 DOI: 10.1177/0269881106063996 |
0.539 |
|
| 2007 |
Manta S, Dong J, Blier P, Debonnel G. P.2.d.012 Vagus nerve stimulation: effects on noradrenergic neuronal firing and serotonin transmission in the rat brain European Neuropsychopharmacology. 17: S368-S369. DOI: 10.1016/S0924-977X(07)70541-2 |
0.372 |
|
| 2006 |
Conductier G, Dusticier N, Lucas G, Côté F, Debonnel G, Daszuta A, Dumuis A, Nieoullon A, Hen R, Bockaert J, Compan V. Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knock-out mouse. The European Journal of Neuroscience. 24: 1053-62. PMID 16930432 DOI: 10.1111/J.1460-9568.2006.04943.X |
0.451 |
|
| 2006 |
Heurteaux C, Lucas G, Guy N, El Yacoubi M, Thümmler S, Peng XD, Noble F, Blondeau N, Widmann C, Borsotto M, Gobbi G, Vaugeois JM, Debonnel G, Lazdunski M. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nature Neuroscience. 9: 1134-41. PMID 16906152 DOI: 10.1038/Nn1749 |
0.378 |
|
| 2006 |
Faure C, Mnie-Filali O, Scarna H, Debonnel G, Haddjeri N. Effects of the 5-HT7 receptor antagonist SB-269970 on rat hormonal and temperature responses to the 5-HT1A/7 receptor agonist 8-OH-DPAT. Neuroscience Letters. 404: 122-6. PMID 16759802 DOI: 10.1016/J.Neulet.2006.05.023 |
0.502 |
|
| 2006 |
Dorr AE, Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. The Journal of Pharmacology and Experimental Therapeutics. 318: 890-8. PMID 16690723 DOI: 10.1124/Jpet.106.104166 |
0.457 |
|
| 2006 |
Robichaud M, Debonnel G. Allopregnanolone and ganaxolone increase the firing activity of dorsal raphe nucleus serotonergic neurons in female rats. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 9: 191-200. PMID 16174428 DOI: 10.1017/S146114570500595X |
0.329 |
|
| 2006 |
Faure C, Mnie-Filali O, Gondard E, Berod A, Didier A, Blier P, Debonnel G, Haddjeri N. P.2.d.006 Serotonin 7 receptor antagonists as putative antidepressants with safer and faster onset of actions European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70377-7 |
0.433 |
|
| 2005 |
Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proceedings of the National Academy of Sciences of the United States of America. 102: 18620-5. PMID 16352709 DOI: 10.1073/Pnas.0509591102 |
0.428 |
|
| 2005 |
Lucas G, Compan V, Charnay Y, Neve RL, Nestler EJ, Bockaert J, Barrot M, Debonnel G. Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5-HT4 agonists. Biological Psychiatry. 57: 918-25. PMID 15820713 DOI: 10.1016/J.Biopsych.2004.12.023 |
0.506 |
|
| 2005 |
Bermack JE, Debonnel G. The role of sigma receptors in depression. Journal of Pharmacological Sciences. 97: 317-36. PMID 15750289 DOI: 10.1254/Jphs.Crj04005X |
0.409 |
|
| 2005 |
Hasegawa S, Watanabe A, Nguyen KQ, Debonnel G, Diksic M. Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study. Psychopharmacology. 179: 781-90. PMID 15619103 DOI: 10.1007/S00213-004-2122-1 |
0.38 |
|
| 2005 |
Bermack JE, Debonnel G. Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus. Synapse (New York, N.Y.). 55: 37-44. PMID 15499608 DOI: 10.1002/Syn.20085 |
0.518 |
|
| 2004 |
Robichaud M, Debonnel G. Modulation of the firing activity of female dorsal raphe nucleus serotonergic neurons by neuroactive steroids Journal of Endocrinology. 182: 11-21. PMID 15225127 DOI: 10.1677/Joe.0.1820011 |
0.379 |
|
| 2004 |
Haddjeri N, Faure C, Lucas G, Mnie-Filali O, Chouvet G, Astier B, Renaud B, Blier P, Debonnel G. In-vivo modulation of central 5-hydroxytryptamine (5-HT1A) receptor-mediated responses by the cholinergic system. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 7: 391-9. PMID 15140278 DOI: 10.1017/S1461145704004377 |
0.533 |
|
| 2004 |
Bermack JE, Haddjeri N, Debonnel G. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus. The Journal of Pharmacology and Experimental Therapeutics. 310: 578-83. PMID 15044555 DOI: 10.1124/Jpet.104.066472 |
0.562 |
|
| 2003 |
Gobbi G, Slater S, Boucher N, Debonnel G, Blier P. Neurochemical and psychotropic effects of bupropion in healthy male subjects. Journal of Clinical Psychopharmacology. 23: 233-9. PMID 12826985 DOI: 10.1097/01.Jcp.0000084023.22282.03 |
0.474 |
|
| 2003 |
Watanabe A, Tohyama Y, Nguyen KQ, Hasegawa S, Debonnel G, Diksic M. Regional brain serotonin synthesis is increased in the olfactory bulbectomy rat model of depression: an autoradiographic study. Journal of Neurochemistry. 85: 469-75. PMID 12675923 DOI: 10.1046/J.1471-4159.2003.01702.X |
0.446 |
|
| 2003 |
Robichaud M, Klink R, Debonnel G. ErratumErratum to “Gender and gonadal status modulation of dorsal raphe nucleus serotonergic neurons. Part II. Regulatory mechanisms”: [Neuropharmacology 43(2002) 1129–1138] Neuropharmacology. 44: 554. DOI: 10.1016/S0028-3908(03)00037-6 |
0.335 |
|
| 2002 |
Klink R, Robichaud M, Debonnel G. Gender and gonadal status modulation of dorsal raphe nucleus serotonergic neurons. Part II. Regulatory mechanisms. Neuropharmacology. 43: 1129-38. PMID 12504919 DOI: 10.1016/S0028-3908(02)00218-6 |
0.475 |
|
| 2002 |
Klink R, Robichaud M, Debonnel G. Gender and gonadal status modulation of dorsal raphe nucleus serotonergic neurons. Part I: Effects of gender and pregnancy Neuropharmacology. 43: 1119-1128. PMID 12504918 DOI: 10.1016/S0028-3908(02)00219-8 |
0.453 |
|
| 2002 |
Lucas G, Debonnel G. 5-HT4 receptors exert a frequency-related facilitatory control on dorsal raphé nucleus 5-HT neuronal activity. The European Journal of Neuroscience. 16: 817-22. PMID 12372017 DOI: 10.1046/J.1460-9568.2002.02150.X |
0.492 |
|
| 2002 |
Bermack J, Lavoie N, Dryver E, Debonnel G. Effects of sigma ligands on NMDA receptor function in the bulbectomy model of depression: a behavioural study in the rat. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 5: 53-62. PMID 12057032 DOI: 10.1017/S1461145701002760 |
0.435 |
|
| 2002 |
Haddjeri N, Chouvet G, Blier P, Zimmer L, Astier B, Renaud B, Debonnel G. 5-HT2/7 receptor antagonists potentiate the effects of antidepressants: An in vivo electrophysiological study European Neuropsychopharmacology. 12: 211. DOI: 10.1016/S0924-977X(02)80223-1 |
0.504 |
|
| 2001 |
Bermack JE, Debonnel G. Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands British Journal of Pharmacology. 134: 691-699. PMID 11588125 DOI: 10.1038/Sj.Bjp.0704294 |
0.506 |
|
| 2001 |
Robichaud M, Beauchemin V, Lavoie N, Dennis T, Debonnel G. Effects of bilateral olfactory bulbectomy on N-methyl-D-aspartate receptor function: autoradiographic and behavioral studies in the rat. Synapse (New York, N.Y.). 42: 95-103. PMID 11574946 DOI: 10.1002/Syn.1105 |
0.448 |
|
| 2001 |
Turcotte JE, Debonnel G, de Montigny C, Hébert C, Blier P. Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 511-21. PMID 11282251 DOI: 10.1016/S0893-133X(00)00220-7 |
0.438 |
|
| 2001 |
Couture S, Debonnel G. Some of the effects of the selective sigma ligand (+)pentazocine are mediated via a naloxone-sensitive receptor Synapse. 39: 323-331. PMID 11169783 DOI: 10.1002/1098-2396(20010315)39:4<323::Aid-Syn1016>3.0.Co;2-1 |
0.463 |
|
| 2000 |
Béïque JC, Blier P, de Montigny C, Debonnel G. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 294-306. PMID 10942853 DOI: 10.1016/S0893-133X(00)00112-3 |
0.498 |
|
| 2000 |
Béïque JC, Montigny CD, Blier P, Debonnel G. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat Neuropharmacology. 39: 1813-1822. PMID 10884562 DOI: 10.1016/S0028-3908(00)00018-6 |
0.445 |
|
| 2000 |
Béïque JC, De Montigny C, Blier P, Debonnel G. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. In vivo electrophysiological studies in the rat Neuropharmacology. 39: 1800-1812. PMID 10884561 DOI: 10.1016/S0028-3908(00)00017-4 |
0.516 |
|
| 1999 |
De Montigny C, Silverstone PH, Debonnel G, Blier P, Bakish D. Venlafaxine in treatment-resistant major depression: A Canadian multicenter, open-label trial Journal of Clinical Psychopharmacology. 19: 401-406. PMID 10505581 DOI: 10.1097/00004714-199910000-00003 |
0.324 |
|
| 1999 |
Bergeron R, De Montigny C, Debonnel G. Pregnancy reduces brain sigma receptor function British Journal of Pharmacology. 127: 1769-1776. PMID 10482906 DOI: 10.1038/Sj.Bjp.0702724 |
0.453 |
|
| 1999 |
Béïque JC, de Montigny C, Blier P, Debonnel G. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites. Synapse (New York, N.Y.). 32: 198-211. PMID 10340630 DOI: 10.1002/(Sici)1098-2396(19990601)32:3<198::Aid-Syn6>3.0.Co;2-2 |
0.504 |
|
| 1999 |
Gronier B, Debonnel G. Involvement of σ receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems European Journal of Pharmacology. 368: 183-196. PMID 10193654 DOI: 10.1016/S0014-2999(99)00025-4 |
0.465 |
|
| 1998 |
Béïque JC, Debonnel G, de Montigny C, Blier P. Discrepancies between the in vitro and in vivo 5-HT and norepinephrine re-uptake blocking properties of venlafaxine. Annals of the New York Academy of Sciences. 861: 290-1. PMID 9928296 DOI: 10.1111/J.1749-6632.1998.Tb10230.X |
0.408 |
|
| 1998 |
Béïque JC, de Montigny C, Blier P, Debonnel G. Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine. British Journal of Pharmacology. 125: 526-32. PMID 9806336 DOI: 10.1038/Sj.Bjp.0702074 |
0.466 |
|
| 1998 |
Béïque JC, Lavoie N, de Montigny C, Debonnel G. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. European Journal of Pharmacology. 349: 129-32. PMID 9669506 DOI: 10.1016/S0014-2999(98)00241-6 |
0.408 |
|
| 1998 |
Couture S, Debonnel G. Modulation of the neuronal response to N-methyl-D-aspartate by selective sigma2 ligands Synapse. 29: 62-71. PMID 9552175 DOI: 10.1002/(Sici)1098-2396(199805)29:1<62::Aid-Syn5>3.0.Co;2-9 |
0.473 |
|
| 1997 |
Bergeron R, De Montigny C, Debonnel G. Effect of short-term and long-term treatments with σ ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus British Journal of Pharmacology. 120: 1351-1359. PMID 9105712 DOI: 10.1038/Sj.Bjp.0701042 |
0.466 |
|
| 1997 |
Bergeron R, Debonnel G. Effects of low and high doses of selective sigma ligands: Further evidence suggesting the existence of different subtypes of sigma receptors Psychopharmacology. 129: 215-224. PMID 9084059 DOI: 10.1007/S002130050183 |
0.394 |
|
| 1996 |
Debonnel G, Bergeron R, De Montigny C. Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: An effect mediated via sigma receptors Journal of Endocrinology. 150. PMID 8943785 DOI: 10.1677/Joe.0.150S033 |
0.49 |
|
| 1996 |
Gronier B, Debonnel G. Electrophysiological evidence for the implication of cholecystokinin in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus Naunyn-Schmiedeberg's Archives of Pharmacology. 353: 382-390. PMID 8935704 DOI: 10.1007/Bf00261434 |
0.49 |
|
| 1996 |
Debonnel G, Bergeron R, Monnet FP, De Montigny C. Differential effects of sigma ligands on the N-methyl-D-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: Effect of mossy fiber lesioning Neuroscience. 71: 977-987. PMID 8684626 DOI: 10.1016/0306-4522(96)80001-7 |
0.385 |
|
| 1996 |
Debonnel G, De Montigny C. Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: Possible implications for the treatment of psychiatric disorders Life Sciences. 58: 721-734. PMID 8632719 DOI: 10.1016/0024-3205(95)02248-1 |
0.409 |
|
| 1996 |
Bergeron R, De Montigny C, Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: Effects mediated via sigma receptors Journal of Neuroscience. 16: 1193-1202. PMID 8558248 DOI: 10.1523/Jneurosci.16-03-01193.1996 |
0.463 |
|
| 1995 |
Gronier B, Debonnel G. CCK(B) Receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: An in vivo electrophysiological study in the rat Synapse. 21: 158-168. PMID 8584977 DOI: 10.1002/Syn.890210209 |
0.426 |
|
| 1995 |
Bouchard P, Monnet F, Bergeron R, Roman F, Junien J‐, de Montigny C, Debonnel G, Quirion R. In Vivo Modulation of Sigma Receptor Sites by Calcitonin Gene‐related Peptide in the Mouse and Rat Hippocampal Formation: Radioligand Binding and Electrophysiological Studies European Journal of Neuroscience. 7: 1952-1962. PMID 8528471 DOI: 10.1111/J.1460-9568.1995.Tb00718.X |
0.413 |
|
| 1995 |
Bergeron R, de Montigny C, Debonnel G. Biphasic effects of sigma ligands on the neuronal response to N-methyl-D-aspartate Naunyn-Schmiedeberg's Archives of Pharmacology. 351: 252-260. PMID 7609778 DOI: 10.1007/Bf00233244 |
0.454 |
|
| 1995 |
Debonnel G, Dryver E, Lavoie N. P-2-9 Effect of sigma ligands on NMDA receptor function in the bulbectomy model of depression: A behavioural study in the rat European Neuropsychopharmacology. 5: 276-277. DOI: 10.1016/0924-977X(95)90374-M |
0.418 |
|
| 1994 |
Monnet FP, Debonnel G, Bergeron R, Gronier B, de Montigny C. The effects of sigma ligands and of neuropeptide Y on N‐methyl‐d‐aspartate‐induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin British Journal of Pharmacology. 112: 709-715. PMID 8075892 DOI: 10.1111/J.1476-5381.1994.Tb13134.X |
0.47 |
|
| 1993 |
Monnet FP, Debonnel G, De Montigny C. The cytochromes P-450 are not involved in the modulation of the N-methyl- D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus Synapse. 13: 30-38. PMID 8427011 DOI: 10.1002/Syn.890130105 |
0.448 |
|
| 1993 |
Bergeron R, Debonnel G, De Montigny C. Modification of the N-methyl-D-aspartate response by antidepressant σ receptor ligands European Journal of Pharmacology. 240: 319-323. PMID 8243549 DOI: 10.1016/0014-2999(93)90918-8 |
0.497 |
|
| 1993 |
Monnet FP, Debonnel G, de Montigny C. Gi/o proteins are involved in the potentiation of N-methyl-D-aspartate (NMDA) effects by sigma agonists and neuropeptide Y European Neuropsychopharmacology. 3: 435-436. DOI: 10.1016/0924-977X(93)90237-G |
0.316 |
|
| 1993 |
Monnet FP, Debonnel G, De Montigny C. Differential effects of high affinity sigma ligands on the NMDA response within rat hippocampus subfields European Neuropsychopharmacology. 3: 434-435. DOI: 10.1016/0924-977X(93)90235-E |
0.385 |
|
| 1993 |
Monnet F, Fournier A, Debonnel G, de Montigny C. Neuropeptide Y selectively potentiates the neuronal response to NMDA in the CA3 region of the rat dorsal hippocampus via a subtype of sigma receptors Neuropeptides. 24: 224-225. DOI: 10.1016/0143-4179(93)90221-U |
0.451 |
|
| 1992 |
Monnet FP, Debonnel G, De Montigny C. In vivo electrophysiological evidence for a selective modulation of N- methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands Journal of Pharmacology and Experimental Therapeutics. 261: 123-130. PMID 1532832 |
0.376 |
|
| 1992 |
Monnet FP, Debonnel G, Fournier A, De Montigny C. Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor Journal of Pharmacology and Experimental Therapeutics. 263: 1219-1225. PMID 1469630 |
0.341 |
|
| 1992 |
Monnet FP, Fournier A, Debonnel G, De Montigny C. Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor Journal of Pharmacology and Experimental Therapeutics. 263: 1212-1218. PMID 1469629 |
0.332 |
|
| 1992 |
Monnet FP, Blier P, Debonnel G, de Montigny C. Modulation by sigma ligands of N-methyl- D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency Naunyn-Schmiedeberg's Archives of Pharmacology. 346: 32-39. PMID 1407002 DOI: 10.1007/Bf00167567 |
0.353 |
|
| 1992 |
de Montigny C, Monnet FP, Fournier A, Debonnel G. Sigma ligands and neuropeptide Y selectively potentiate the NMDA response in the rat CA3 dorsal hippocampus: in vivo electrophysiological studies Clinical Neuropharmacology. 15. PMID 1323387 DOI: 10.1097/00002826-199201001-00078 |
0.386 |
|
| 1992 |
Bergeron R, Debonnel G, Montigny Cd. Modulation Of The Response Of Rat Hippocampal Pyramidal Neurons To Nmda By Antidepressant Sigma Ligands: Evidence For Different Subtypes Of Sigma Receptors. Clinical Neuropharmacology. 15. DOI: 10.1097/00002826-199202001-00021 |
0.477 |
|
| 1992 |
Debonnel G, Monnet FP, Montigny Cd. Differential Effects Of High Affinity Sigma Ligands And Of Neuropeptide Y On The Nmda Response Within Rat Hippocampus Subfields. Clinical Neuropharmacology. 15. DOI: 10.1097/00002826-199202001-00020 |
0.389 |
|
| 1990 |
Monnet FP, Debonnel G, de Montigny C. Neuropeptide Y selectively potentiates N-methyl-D-aspartate-induced neuronal activation European Journal of Pharmacology. 182: 207-208. PMID 2205507 DOI: 10.1016/0014-2999(90)90516-9 |
0.421 |
|
| 1990 |
Monnet FP, Debonnel G, Junien JL, De Montigny C. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors European Journal of Pharmacology. 179: 441-445. PMID 2163857 DOI: 10.1016/0014-2999(90)90186-A |
0.474 |
|
| 1989 |
Debonnel G, Weiss M, De Montigny C. Reduced neuroexcitatory effect of domoic acid following mossy fiber denervation of the rat dorsal hippocampus: Further evidence that toxicity of domoic acid involves kainate receptor activation Canadian Journal of Physiology and Pharmacology. 67: 904-908. PMID 2557145 DOI: 10.1139/Y89-142 |
0.401 |
|
| 1987 |
Debonnel G, de Montigny C. Pipequaline acts as a partial agonist of benzodiazepine receptors: An electrophysiological study in the hippocampus of the rat Neuropharmacology. 26: 1337-1342. PMID 2823163 DOI: 10.1016/0028-3908(87)90096-7 |
0.466 |
|
| Show low-probability matches. |